A call to prevent unsafe high-risk medical devices from reaching the marketplace

January 22, 2013
This is Rita F. Redberg, M.D., M.Sc., professor of medicine and director of the UCSF Women's Cardiovascular Services. Credit: Susan Merrell/UCSF

Technological advancements in medicine have allowed patients suffering from musculoskeletal conditions such as hip and knee pain to regain mobility and live relatively pain-free. But some "high risk" surgical devices that have been approved by the U.S. Food and Drug Administration (FDA) are not required to go through clinical trials, where a product is tested to determine its safety and effectiveness.

"This could be potentially very dangerous. Many Americans – patients and even physicians - are not aware of how many devices in this country are on the market without having clinical data of safety and effectiveness," said Rita F Redberg, MD, MSc, professor of medicine and director of the UCSF Women's Cardiovascular Services.

UCSF and the Australian Joint Registry published this month a perspective in the that reveals the complex history of how metal-on-metal hip implants reached the marketplace. The implants are categorized by the FDA as high-risk devices, yet have been allowed into the marketplace without first testing them. They failed at a dangerously high rate, often requiring reparative surgery at least four times as often as traditional .

The perspective's authors are calling for changes in how the FDA approves metal-on-metal hip replacement devices and other high-risk devices for the marketplace.

"If those are recalled, besides the problem of having to remove them because they're very painful, they can release chromium ions into the blood stream which pose an unknown risk," Redberg said. "Patients would also undergo significant disability having a second, third or fourth hip operation."

U.S. hospitals perform 48 million medical procedures each year, according to the U.S. . Of that number, roughly 676,000 patients undergo total surgeries and 327,000 undergo total surgeries.

"Some patients' mobility will decline to the point of needing walkers or wheelchairs to get around and other serious events up to and including death can occur from subsequent operations," Redberg said. "And that's just for the metal-on-metal implants."

An Obscure Loophole

These high-risk metal-on-metal devices avoid going through clinical trials because of FDA loopholes in the 510(k) clearance, which allow them into the marketplace by claiming "substantial equivalence," which means they are similar to already approved devices or "predicate devices."

"All you have to do is show that your device is substantially similar to a number of other devices," Redberg said. "And some of those devices which were originally approved have been recalled or pulled off the market, but their original approval was still allowed for those 'predicate devices' that claimed 'substantial equivalence.'"

Even voluntarily recalled devices can serve as predicates under the 510(k) clearance as long as the FDA did not require their removal from the market or a court did not find they were misbranded or misrepresented in any way.

"High-risk medical devices should go through randomized clinical trials done in people so we can assure patients they are safe and effective," Redberg said. "Even the more stringent pre-market approval (PMA) process doesn't always mean that you actually have gone through randomized clinical trials, so we have to make sure these devices not only go through pre-market approval but randomized clinical trials as well."

Questions to Ask

For patients who are in the process of undergoing a medical procedure, Redberg suggests they stay informed and ask many questions.

"Just like for any kind of procedure, I would ask, 'Are there scientific data that show this procedure or is going to help me?'" Redberg said. "'Has it been studied in ? Has it been studied in patients like me? What are the risks? What are the alternatives?' Those are the questions patients should be asking before every procedure."

Explore further: New hip implants no better than traditional implants

Related Stories

New hip implants no better than traditional implants

November 30, 2011
New hip implants appear to have no advantage over traditional implants, suggests a review of the evidence published in the British Medical Journal today.

FDA probing safety of metal-on-metal hip implants

June 27, 2012
(HealthDay) -- While thousands of Americans have benefited from hip replacements over the years, problems with metal-on-metal implants can lead to troubles requiring surgery to replace defective devices, experts say.

US panel sees little use for metal-on-metal hips

June 29, 2012
(AP) — U.S. government health experts said Thursday there are few reasons to continue using metal-on-metal hip implants, amid growing evidence that the devices can break down early and expose patients to dangerous metallic ...

Metal-on-metal hip replacement patients at no more risk of developing cancer

April 3, 2012
Patients who have had metal-on-metal hip replacements are no more likely to develop cancer in the first seven years after surgery than the general population, although a longer-term study is required, a study published in ...

UK says metal hip replacements more troublesome

September 16, 2011
(AP) -- People who get metal hip replacements are more likely to need a replacement compared to those who get a traditional plastic one, according to a new report from a large British registry.

Recommended for you

High-fat diet in pregnancy can cause mental health problems in offspring

July 21, 2017
A high-fat diet not only creates health problems for expectant mothers, but new research in an animal model suggests it alters the development of the brain and endocrine system of their offspring and has a long-term impact ...

To combat teen smoking, health experts recommend R ratings for movies that depict tobacco use

July 21, 2017
Public health experts have an unusual suggestion for reducing teen smoking: Give just about any movie that depicts tobacco use an automatic R rating.

Opioids and obesity, not 'despair deaths,' raising mortality rates for white Americans

July 20, 2017
Drug-related deaths among middle-aged white men increased more than 25-fold between 1980 and 2014, with the bulk of that spike occurring since the mid-1990s when addictive prescription opioids became broadly available, according ...

Aging Americans enjoy longer life, better health when avoiding three risky behaviors

July 20, 2017
We've heard it before from our doctors and other health experts: Keep your weight down, don't smoke and cut back on the alcohol if you want to live longer.

Parents have critical role in preventing teen drinking

July 20, 2017
Fewer teenagers are drinking alcohol but more needs to be done to curb the drinking habits of Australian school students, based on the findings of the latest study by Adelaide researchers.

Fresh fish oil lowers diabetes risk in rat offspring

July 19, 2017
Fresh fish oil given to overweight pregnant rats prevented their offspring from developing a major diabetes risk factor, Auckland researchers have found.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.